Showing results (421-430 of 441) with videos related to

Sort By:
Pageof 45
Frontiers in Pharmacology|March 21, 2022
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?Nils Helge Schebb, Hartmut Kühn, Astrid S Kahnt, et al.
Journal of Medicinal Chemistry|November 24, 2015
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ ModulatorsRené Blöcher, Christina Lamers, Sandra K Wittmann, et al.
Journal of Medicinal Chemistry|October 12, 2020
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-LipoxygenaseKerstin Hiesinger, Jan S Kramer, Sandra Beyer, et al.
Nature Communications|August 4, 2019
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLThomas Oellerich, Constanze Schneider, Dominique Thomas, et al.
Biochemical Pharmacology|November 9, 2016
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418Isabelle V Maucher, Michael Rühl, Simon B M Kretschmer, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 13, 2021
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cellsTamara Rothenburger, Dominique Thomas, Yannick Schreiber, et al.
Pageof 45